Mingxi Lin
Impact in
-
- Immune cells in cancer
- Immune Response and Inflammation
-
- NF-κB Signaling Pathways
Papers in ⓘ
- Oncology 11
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 3
- Cancer Diagnosis and Treatment 3
- Cytokine Signaling Pathways and Interactions 2
-
- Breast Cancer Treatment Studies 3
- Co-authors
- Yizi Jin (11 shared papers)Jian Zhang (3 shared papers)Cheng Zeng (3 shared papers)Teng Zhou (2 shared papers)Xiaomin Ye (1 shared paper)Xin Shen (1 shared paper)Qing Guo (1 shared paper)Xinyu Chen (1 shared paper)
In The Last Decade
Mingxi Lin
19 papers receiving 964 citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Immunology 178
- Cancer Research 124
- Biological Psychiatry 19
- Neurology 43
- Oncology 140
Countries citing papers authored by Mingxi Lin
This map shows the geographic impact of Mingxi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxi Lin more than expected).
Fields of papers citing papers by Mingxi Lin
This network shows the impact of papers produced by Mingxi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxi Lin. The network helps show where Mingxi Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingxi Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | NF-κB in biology and targeted therapy: new insights and translational implications Hit paper breakdown → | 2024 | 799 |
| 2 | 2018 | 66 | |
| 3 | 2020 | 34 | |
| 4 | 2020 | 16 | |
| 5 | 2016 | 14 | |
| 6 | 2024 | 12 | |
| 7 | 2020 | 7 | |
| 8 | 2020 | 6 | |
| 9 | 2021 | 4 | |
| 10 | 2025 | 3 | |
| 11 | 2024 | 3 | |
| 12 | 2021 | 3 | |
| 13 | 2022 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2025 | 1 | |
| 16 | 2023 | 1 | |
| 17 | 2025 | 1 | |
| 18 | Discussion on diabetes mellitus based on ‘spirit, physique, appetite, sleeping, urine and stool' | 2014 | 1 |
| 19 | 1989 | 1 | |
| 20 | 2021 | 0 |
About Mingxi Lin
Mingxi Lin is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Developmental Neuroscience and Genetics, having authored 20 papers that have together received 976 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (6 papers), Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Diagnosis and Treatment (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Brain Metastases and Treatment (2 papers) and RNA and protein synthesis mechanisms (2 papers). The work is most often cited by research in Immunology (178 citations), Cancer Research (124 citations), Biological Psychiatry (19 citations), Neurology (43 citations) and Oncology (140 citations). Mingxi Lin has collaborated with scholars based in China, Taiwan and Spain. Frequent co-authors include Yizi Jin, Jian Zhang, Cheng Zeng, Teng Zhou, Xiaomin Ye, Xin Shen, Qing Guo, Xinyu Chen, Jie Liu and Xiuwei Fan. Their work appears in journals such as Cancer Medicine, Journal of Cancer, Cancer Research and Treatment, International Journal of Legal Medicine and EMBO Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.